Stability of bupropion and its major metabolites in human plasma

Steven Laizure, C. Lindsay Devane

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Summary: Bupropion (BUP) is a new, monocyclic, second-generation antidepressant with efficacy comparable with that of the tricyclics but possessing a more favorable side-effect profile. Therapeutic drug monitoring services are expected to be widely available following the marketing of BUP, yet relatively little has been published on its clinical pharmacokinetics. The purpose of this study was to assess the drug's plasma stability and to determine the best storage conditions for conducting pharmacokinetic studies of BUP and its major metabolites. Human plasma was spiked with known concentrations of BUP and its major basic metabolites, threo-amino alcohol (TB), erythro-amino alcohol (EB), and hydroxy metabolite (HB), and incubated under varying conditions of temperature and pH. BUP showed a log linear degradation that was both temperature and pH dependent. BUP half-life in pH 7.4 plasma stored at 22 and 37°C was 54.2 and 11.4 h, respectively. Incubation at 37°C, pH 2.5 to 10, for 48 h had minimal effect on metabolite concentrations. These results indicate that drug degradation must be considered in studies involving the incubation of plasma for protein binding determinations and the collection and storage of plasma samples for drug concentration analysis during therapeutic drug monitoring.

Original languageEnglish (US)
Pages (from-to)447-450
Number of pages4
JournalTherapeutic Drug Monitoring
Volume7
Issue number4
DOIs
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Bupropion
Amino Alcohols
Drug Monitoring
Pharmacokinetics
Drug Stability
Temperature
Marketing
Protein Binding
Pharmaceutical Preparations
Antidepressive Agents
Half-Life
Blood Proteins

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Stability of bupropion and its major metabolites in human plasma. / Laizure, Steven; Devane, C. Lindsay.

In: Therapeutic Drug Monitoring, Vol. 7, No. 4, 01.01.1985, p. 447-450.

Research output: Contribution to journalArticle

@article{196ea241ca094b04af2ac3a57322f44d,
title = "Stability of bupropion and its major metabolites in human plasma",
abstract = "Summary: Bupropion (BUP) is a new, monocyclic, second-generation antidepressant with efficacy comparable with that of the tricyclics but possessing a more favorable side-effect profile. Therapeutic drug monitoring services are expected to be widely available following the marketing of BUP, yet relatively little has been published on its clinical pharmacokinetics. The purpose of this study was to assess the drug's plasma stability and to determine the best storage conditions for conducting pharmacokinetic studies of BUP and its major metabolites. Human plasma was spiked with known concentrations of BUP and its major basic metabolites, threo-amino alcohol (TB), erythro-amino alcohol (EB), and hydroxy metabolite (HB), and incubated under varying conditions of temperature and pH. BUP showed a log linear degradation that was both temperature and pH dependent. BUP half-life in pH 7.4 plasma stored at 22 and 37°C was 54.2 and 11.4 h, respectively. Incubation at 37°C, pH 2.5 to 10, for 48 h had minimal effect on metabolite concentrations. These results indicate that drug degradation must be considered in studies involving the incubation of plasma for protein binding determinations and the collection and storage of plasma samples for drug concentration analysis during therapeutic drug monitoring.",
author = "Steven Laizure and Devane, {C. Lindsay}",
year = "1985",
month = "1",
day = "1",
doi = "10.1097/00007691-198512000-00015",
language = "English (US)",
volume = "7",
pages = "447--450",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Stability of bupropion and its major metabolites in human plasma

AU - Laizure, Steven

AU - Devane, C. Lindsay

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Summary: Bupropion (BUP) is a new, monocyclic, second-generation antidepressant with efficacy comparable with that of the tricyclics but possessing a more favorable side-effect profile. Therapeutic drug monitoring services are expected to be widely available following the marketing of BUP, yet relatively little has been published on its clinical pharmacokinetics. The purpose of this study was to assess the drug's plasma stability and to determine the best storage conditions for conducting pharmacokinetic studies of BUP and its major metabolites. Human plasma was spiked with known concentrations of BUP and its major basic metabolites, threo-amino alcohol (TB), erythro-amino alcohol (EB), and hydroxy metabolite (HB), and incubated under varying conditions of temperature and pH. BUP showed a log linear degradation that was both temperature and pH dependent. BUP half-life in pH 7.4 plasma stored at 22 and 37°C was 54.2 and 11.4 h, respectively. Incubation at 37°C, pH 2.5 to 10, for 48 h had minimal effect on metabolite concentrations. These results indicate that drug degradation must be considered in studies involving the incubation of plasma for protein binding determinations and the collection and storage of plasma samples for drug concentration analysis during therapeutic drug monitoring.

AB - Summary: Bupropion (BUP) is a new, monocyclic, second-generation antidepressant with efficacy comparable with that of the tricyclics but possessing a more favorable side-effect profile. Therapeutic drug monitoring services are expected to be widely available following the marketing of BUP, yet relatively little has been published on its clinical pharmacokinetics. The purpose of this study was to assess the drug's plasma stability and to determine the best storage conditions for conducting pharmacokinetic studies of BUP and its major metabolites. Human plasma was spiked with known concentrations of BUP and its major basic metabolites, threo-amino alcohol (TB), erythro-amino alcohol (EB), and hydroxy metabolite (HB), and incubated under varying conditions of temperature and pH. BUP showed a log linear degradation that was both temperature and pH dependent. BUP half-life in pH 7.4 plasma stored at 22 and 37°C was 54.2 and 11.4 h, respectively. Incubation at 37°C, pH 2.5 to 10, for 48 h had minimal effect on metabolite concentrations. These results indicate that drug degradation must be considered in studies involving the incubation of plasma for protein binding determinations and the collection and storage of plasma samples for drug concentration analysis during therapeutic drug monitoring.

UR - http://www.scopus.com/inward/record.url?scp=0022398283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022398283&partnerID=8YFLogxK

U2 - 10.1097/00007691-198512000-00015

DO - 10.1097/00007691-198512000-00015

M3 - Article

VL - 7

SP - 447

EP - 450

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 4

ER -